IA-2 autoantibodies predict impending Type I diabetes in siblings of patients

Diabetologia

Volumn 45, Issue 12, 2002, Pages 1658-1666

  Decochez, K ^a   De Leeuw, I H ^b   Keymeulen, B ^a   Mathieu, C ^c   Rottiers, R ^d   Weets, I ^a   Vandemeulebroucke, E ^a   Truyen, I ^a   Kaufman, L ^a   Schuit, F C ^a   Pipeleers, D G ^a   Gorus, Frans K ^a,e   Arnouts, P ^f   Baeyens, J P ^f   Balasse, E ^f   Beckers, D ^f   Becq, H ^f   Beirinckx, J ^f   Bettens, W ^f   Bouillon, R ^f   Bourguignon, J ^f   Brusaard, H ^f   Buysschaert, M ^f   Cardon, A ^f   Carlier, A ^f   Claeys, I ^f   Claeys, L ^f   Cochez, P ^f   Coeckelberghs, M ^f   Coolens, J L ^f   Corvilain, B ^f   Couke, F ^f   Coucke, W ^f   Couturier, E ^f   Craen, R ^f   Daubresse, J C ^f   Decraene, P ^f   De Feyter, I ^f   Delvigne, C ^f   Demaeseneer, R ^f   De Proft, G ^f   De Schepper, J ^f   De Wasch, G ^f   De Weer, S ^f   Dooms, L ^f   Dorchy, H ^f   Du Caju, M ^f   Duvivier, E ^f   Emsens, L ^f   Ernould, C ^f   Eykens, A ^f   Fery F ^f   Garmijn, K ^f   Gillet, C ^f   Guiot, C ^f   Haemers, A ^f   Heemers, S ^f   Herbaut, C ^f   Janssen, R ^f   Jopart, P ^f   Krzentowski, G ^f   Lamberigts, G ^f   Lebrethon, M C ^f   Lefebvre P ^f   Letiexhe, M ^f   Lim, T T ^f   Logghe, K ^f   Maes, M ^f   Maes, W ^f   Mockel, J ^f   Monballyu, J ^f   Moorkens, G ^f   Muls, E ^f   Musch, W ^f   Nicolajj, D ^f   Nobels, F ^f   Peiffer, F ^f   Pelekmans, M C ^f   Penninckx, H ^f   Peters, O ^f   Plat Kuthowska, L ^f   Purnode, A ^f   Rocour Brumioul, D ^f   Roggemans, M P ^f   Rooman, R ^f   Rubens, R ^f   Scheen, A ^f   Schutyeer, J ^f   Segers, O ^f   Somers, G ^f   Taelman, P ^f   Terriere, L ^f   Teuwen, J ^f   Thenaers, G ^f   Tits, J ^f   Van Acker, K ^f   Van Acken, E ^f   Van Crombrugge, P ^f   Van de Mierop, L ^f   more..

^a FREE UNIVERSITY OF BRUSSELS   (Belgium)

^b UNIVERSITY OF ANTWERP   (Belgium)

^c UNIVERSITY OF LEUVEN   (Belgium)

^d GHENT UNIVERSITY   (Belgium)

^e VRIJE UNIVERSITEIT BRUSSEL   (Belgium)

^f NONE

Author keywords

GAD autoantibodies; HLA DQ; IA 2 autoantibodies; Insulin autoantibodies; Islet cell antibodies; Prediction; Prevention; Siblings; Type I diabetes

Indexed keywords

AUTOANTIBODY; GLUTAMATE DECARBOXYLASE; IA ANTIBODY; IA ANTIGEN; INSULIN; PANCREAS ISLET CELL ANTIBODY; ICA512 AUTOANTIBODY; INSULIN ANTIBODY; ISOENZYME;

ADOLESCENT; ADULT; ARTICLE; CHILD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CYTOPLASM; DISEASE COURSE; DISEASE MARKER; FEMALE; FOLLOW UP; HUMAN; INFORMATION PROCESSING; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; MALE; PANCREAS ISLET CELL; PREDICTION; PRIORITY JOURNAL; RISK; SIBLING; SURVIVAL; GENETICS; IMMUNOLOGY; INFANT; LONGITUDINAL STUDY; NEWBORN; PREDICTION AND FORECASTING; PRESCHOOL CHILD; PROPORTIONAL HAZARDS MODEL; RISK ASSESSMENT;

ADOLESCENT; ADULT; AUTOANTIBODIES; CHILD; CHILD, PRESCHOOL; DIABETES MELLITUS, TYPE 1; FEMALE; GLUTAMATE DECARBOXYLASE; HUMANS; INFANT; INFANT, NEWBORN; INSULIN ANTIBODIES; ISOENZYMES; LONGITUDINAL STUDIES; MALE; PREDICTIVE VALUE OF TESTS; PROPORTIONAL HAZARDS MODELS; RISK ASSESSMENT;

EID: 0036460367     PISSN: 0012186X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00125-002-0949-8     Document Type: Article

References (36)

1. Verge CF, Gianani R, Kawasaki E et al. (1996) Prediction of type 1 diabetes in first degree relatives using a combination of insulin, GAD and ICA.512 bdc/IA-2 autoantibodies. Diabetes 45:926-933
2. 65-autoantibodies in new onset IDDM patients and help predict impending diabetes in their siblings. Diabetologia 40:95-99
3. Bingley PJ, Bonifacio E, Gale EAM (1993) Can we predict insulin-dependent diabetes mellitus? Diabetes 42:213-220
4. Kulmala P, Savola K, Petersen JS et al. (1997) Prediction of insulin-dependent diabetes mellitus in siblings of children with diabetes. J Clin Invest 101:327-336
5. Leslie RDG, Atkinson MA, Notkins AL (1999) Autoantigens IA-2 and GAD in Type I (insulin-dependent) diabetes. Diabetologia 42:3-14
6. Gale EAM, Gillespie KM (2001) Diabetes and gender. Diabetologia 44:3-15
7. Bingley PJ, Christie MR, Bonifacio E et al. (1994) Combined analysis of autoantibodies inproves prediction of IDDM in islet-cell antibody positive relatives. Diabetes 43:1304-1310
8. Maclaren N, Lan M, Coutant R et al. (1999) Only multiple autoantibodies to islet cells (ICA), insulin, GAD65, IA-2 and IA-2β predict immune-mediated (type 1) diabetes in relatives. J Autoimmun 12:279-287
9. Bingley PJ, for the ICARUS group (1996) Interactions of age, islet cell antibodies, insulin autoantibodies and first-phase insulin response in predicting progression to IDDM in relatives: The ICARUS dataset. Diabetes 45:1720-1728
10. Yu L, Cuthbertson DD, Maclaren N et al. (2001) Expression of GAD65 and islet cell antibody (ICA 512) autoanti-bodies among cytoplasmic ICA positive relatives is associated with eligibility for the Diabetes Prevention Trial -Type 1. Diabetes 50:1735-1740
11. Mahon JL, Dupré J (1997) The limitations of clinical trials for prevention of IDDM. Diabetes Care 20:1027-1033
12. National Diabetes Data Group (1979) Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance. Diabetes 28:1039-1057
13. Decochez K, Tits J, Coolens J-L et al. (2000) High frequency of persisting or increasing islet-specific autoanti-body levels after diagnosis of insulin-requiring type 1 diabetes presenting before age 40 years. Diabetes Care 23:838-844
14. Verge CF, Stenger D, Bonifacio E et al. (1998) Combined use of autoantibodies (IA-2 autoantibody, GAD autoanti-body, insulin, autoantibody, cytoplasmic islet cell antibodies) in type 1 diabetes. Diabetes 47:1857-1866
15. Van der Auwera B, Schuit F, Lyaruu I et al. (1995) Genetic susceptibility for insulin-dependent diabetes mellitus in Caucasians revisited: The importance of diabetes registries in disclosing interactions between HLA DQ and insulin gene-limited risk. J Clin Endocrinol Metab 80:2567-2573
16. Kaplan EL, Meier P (1958) Nonparametric estimation from incomplete observations. J Am Stat Assoc 53:457-481
17. Mantel N (1988) Evaluation of survival data and two new rank order statistics arising in its consideration. Cancer Chemother Rep 50:163-170
18. Cox DR (1972) Regression models and life-tables. J R Stat Soc [B] 34:187-220
19. Williams AJK, Bingley PJ, Bonifacio E, Palmer JP, Gale EAM (1997) A novel micro-assay for insulin autoanti-bodies. J Autoimmun 10:473-478
20. Bingley PJ, Bonifacio E, Mueller P et al. (2001) Diabetes antibody standardisation programme: First assay proficiency evaluation. Diabetologia 44 [Suppl 1]:A74 (Abstract)
21. Tiberti C, Yu L, Verrienti A et al. (2001) The IA-2 intracellular fragment (a.a. 761-964) is the most sensitive marker of IA-2 autoimmunity in Type I diabetes. Diabetologia 44 [Suppl 1]:A32 (Abstract)
22. Lobner K, Steinbrenner H, Roberts GA et al. (2001) The protein tyrosine phosphatase like molecule IA-2 as a model for paracrine regulation by insulin. Diabetologia 44 [Suppl 1]:A30 (Abstract)
23. Kulmala P, Savola K, Reijonen H et al. (2000) Genetic markers, humoral autoimmunity, and prediction of type 1 diabetes in siblings of affected children. Diabetes 49:48-58
24. Caillat-Zucman S, Garchon HJ, Timsit J et al. (1992) Age-dependent HLA genetic heterogeneity of type 1 insulin-dependent diabetes mellitus. J Clin Invest 90:2242-2250
25. Krolewski AS, Warram JH, Rand LI, Kahn CR (1987) Epidemiologic approach to the etiology of type 1 diabetes mellitus and its complications. N Engl J Med 317:1390-1398
26. Yu L, Robles DT, Abiru N et al. (2000) Early expression of antiinsulin autoantibodies of humans and the NOD mouse: Evidence for early determination of subsequent diabetes. Proc Natl Acad Sci USA 97:1701-1706
27. Ziegler AG, Hummel M, Schenker M, Bonifacio E (1999) Autoantibody appearance and risk for development of childhood diabetes in offspring of parents with type 1 diabetes: The 2-year analysis of the German BABY-DIAB Study. Diabetes 48:460-468
28. Kimpimäki T, Kupila A, Hämäläinen A-M et al. (2001) The first signs of β-cell autoimmunity appear in infancy in genetically susceptible children from the general population: The Finnish type 1 diabetes prediction and prevention study. J Clin Endocrinol Metab 86:4782-4788
29. Yu L, Rewers M, Gianani R et al. (1996) Antiislet autoanti-bodies usually develop sequentially rather than simultaneously. J Clin Endocrinol Metab 81:4264-4267
30. Payton MA, Hawkes CJ, Christie MR (1995) Relationship of the 37,000- and 40,000-Mr tryptic fragments of islet antigens in insulin-dependent diabetes to the protein tyrosine phosphatase-like molecule IA-2 (ICA512). J Clin Invest 96:1506-1511
31. Christie MR, Tun RYM, Lo SSS et al. (1992) Antibodies to glutamic acid decarboxylase and tryptic fragments of islet 64kD antigen as distinct markers for the development of insulin-dependent diabetes. Studies with identical twins. Diabetes 41:782-787
32. Bingley PJ, Christie MR, Bonifacio E et al. (1994) Combined analysis of autoantibodies improves prediction in islet cell antibody positive relatives. Diabetes 43:1291-1296
33. Christie MR, Genovese S, Cassidy D et al. (1994) Antibodies to islet 37 k antigen, but not to glutamate decarboxylase, discriminate rapid progression to IDDM in endocrine autoimmunity. Diabetes 43:1254-1259
34. Genovese S, Bingley PJ, Bonifacio E et al. (1994) Combined analysis of IDDM-related autoantibodies in healthy schoolchildren. Lancet 344:756
35. Diabetes Prevention Trial - Type 1 Diabetes Study Group (2002) Effects of insulin in relatives of patients with type 1 diabetes mellitus. N Engl J Med 346:1685-1691
36. Smith CP, Tarn AC, Thomas JM et al. (1989) Between and within subject variation of the first phase insulin response to intravenous glucose. Diabetologia 31:123-125